Genetic Demonstration of a Redundant Role of Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Mitogen-Activated Protein Kinases in Promoting Fibroblast Proliferation
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The extracellular signal-regulated kinase 1 and 2 (ERK1/2) mitogen-activated protein (MAP) kinase signaling pathway plays an important role in the proliferative response of mammalian cells to mitogens. However, the individual contribution of the isoforms ERK1 and ERK2 to cell proliferation control is unclear. The two ERK isoforms have similar biochemical properties and recognize the same primary sequence determinants on substrates. On the other hand, analysis of mice lacking individual ERK genes suggests that ERK1 and ERK2 may have evolved unique functions. In this study, we used a robust genetic approach to analyze the individual functions of ERK1 and ERK2 in cell proliferation using genetically matched primary embryonic fibroblasts. We show that individual loss of either ERK1 or ERK2 slows down the proliferation rate of fibroblasts to an extent reflecting the expression level of the kinase. Moreover, RNA interference-mediated silencing of ERK1 or ERK2 expression in cells genetically disrupted for the other isoform similarly reduces cell proliferation. We generated fibroblasts genetically deficient in both Erk1 and Erk2. Combined loss of ERK1 and ERK2 resulted in a complete arrest of cell proliferation associated with G(1) arrest and premature replicative senescence. Together, our findings provide compelling genetic evidence for a redundant role of ERK1 and ERK2 in promoting cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“Although the molecular mechanisms underlying the establishment of the senescent state remain to be investigated, we speculate that the stable inhibition of E2F activity and the resulting silencing of E2F target genes contribute to this process (8, 44).”
BackgroundDifferential regulation and properties of MAPKs
Raman, M., Chen, W., & Cobb, M. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210392 · Cited by 1,430 · cited 1×
“Signaling output from the ERK1/2 MAP kinase pathway is modulated by interactions with scaffolds and regulatory proteins, which regulate the localization, amplitude, and duration of the signal (13, 42, 49).”
BackgroundMeloche, S., & Pouysségur, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210414 · Cited by 1,091 · cited 3×
“Cyclin D1, Tob1, c-Myc, and p27 are known transcriptional targets of the ERK1/2 pathway (26, 41, 63, 68, 69, 71), which also impacts on the stability of c-Myc protein (54) and on the activity of Tob1 (57).”
BackgroundSelf-citationThe RSK family of kinases: emerging roles in cellular signalling
Anjum, R., & Blenis, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2509 · Cited by 777
Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice
Pagès, G., Guérin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., & Pouysségur, J. (1999) · Science · doi:10.1126/science.286.5443.1374 · Cited by 654
Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D. P., Pagès, G., Valverde, O., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00716-x · Cited by 456
An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development
Saba‐El‐Leil, M. K., Vella, F. D. J., Vernay, B., Voisin, L., Chen, L., Labrecque, N., Ang, S., & Meloche, S. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor939 · Cited by 366 · cited 6×
“Analysis of mouse models has revealed that disruption of the Erk2 gene leads to early embryonic lethality, despite the wide expression of ERK1 in early mouse embryos (20, 52, 70).”
BackgroundMethodInfluentialSelf-citationExtracellular signal-regulated kinase 2 is necessary for mesoderm differentiation
Yao, Y., Li, W., Wu, J., Germann, U. A., Su, M. S. S., Kuida, K., & Boucher, D. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134254100 · Cited by 323 · cited 3×
“5 from a defect in trophoblast development (52, 70), thereby precluding the isolation of embryonic fibroblasts.”
BackgroundEssential role for ERK2 mitogen‐activated protein kinase in placental development
Hatano, N., Mori, Y., Oh‐hora, M., Kosugi, A., Fujikawa, T., Nakai, N., Niwa, H., Miyazaki, J., Hamaoka, T., & Ogata, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00680.x · Cited by 296
ERK2 is required for efficient terminal differentiation of skeletal myoblasts
Li, J., & Johnson, S. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.051 · Cited by 137
Research works printed but not linked: 63
- 10.1002/ijc.24604 · DOI · Paper page
- 10.2337/diabetes.54.2.402 · DOI · Paper page
- 10.1091/mbc.2.5.357 · DOI · Paper page
- 10.1016/0092-8674(91)90098-J · DOI · Paper page
- 10.1126/science.2164259 · DOI · Paper page
- Bourcier C., 2006, Cancer Res, 66, 2700, 10.1158/0008-5472.CAN-05-3129 · DOI · Paper page
- Chang F., 2003, Int. J. Oncol, 22, 469
- 10.1016/0022-1759(86)90368-6 · DOI · Paper page
- 10.1002/cne.21186 · DOI
- 10.1073/pnas.92.20.9363 · DOI · Paper page
- 10.1242/jcs.02505 · DOI · Paper page
- 10.1016/j.immuni.2005.08.013 · DOI · Paper page
- 10.1002/hep.22730 · DOI
- 10.1002/hep.21551 · DOI · Paper page
- 10.1093/emboj/16.8.1921 · DOI · Paper page
- Giasson E., 1995, J. Biol. Chem, 270, 5225, 10.1074/jbc.270.10.5225 · DOI
- 10.1016/S0021-9258(18)54548-8 · DOI · Paper page
- Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
- Jha K. K., 1998, Exp. Cell Res, 245, 1, 10.1006/excr.1998.4272 · DOI
- 10.1074/jbc.M211739200 · DOI · Paper page
- Kim-Kaneyama J., 2000, J. Biol. Chem, 275, 20685, 10.1074/jbc.M908723199 · DOI
- Koppen A., 2007, Eur. J. Cancer, 43, 2413, 10.1016/j.ejca.2007.07.024 · DOI
- 10.1074/jbc.271.34.20608 · DOI · Paper page
- 10.1128/MCB.00800-07 · DOI · Paper page
- 10.4161/cc.8.5.7734 · DOI · Paper page
- Leung J. Y., 2008, Oncogene, 27, 4172, 10.1038/onc.2008.55 · DOI
- 10.1016/S0065-230X(08)60765-4 · DOI · Paper page
- 10.1161/01.CIR.0000127126.73759.23 · DOI · Paper page
- 10.1038/sj.onc.1207188 · DOI
- Lloyd A. C., 2006, J. Biol, 5, 13, 10.1186/jbiol46 · DOI
- 10.1073/pnas.161269798 · DOI · Paper page
- Lorenzini A., 2002, Exp. Gerontol, 37, 1149, 10.1016/S0531-5565(02)00133-X · DOI
- 10.1371/journal.pone.0003873 · DOI · Paper page
- 10.1038/nature03094 · DOI · Paper page
- 10.1002/jcp.1041630319 · DOI
- 10.1146/annurev.cellbio.19.111401.091942 · DOI · Paper page
- 10.1073/pnas.90.18.8424 · DOI · Paper page
- Nekrasova T., 2005, J. Immunol, 175, 2374, 10.4049/jimmunol.175.4.2374 · DOI · Paper page
- 10.1128/MCB.14.1.463 · DOI
- 10.1210/er.22.2.153 · DOI · Paper page
- 10.1016/S0021-9258(18)53507-9 · DOI · Paper page
- Rodier G., 2005, J. Cell Biol, 168, 55, 10.1083/jcb.200404146 · DOI
- 10.1210/mend.11.13.0036 · doi:10.1210/mend.11.13.0036 · Paper page
- 10.1101/gad.836800 · DOI · Paper page
- 10.1083/jcb.148.3.543 · DOI
- Shohet J. M., 2002, Cancer Res, 62, 1123
- 10.1101/gad.962802 · DOI
- 10.1242/dev.00893 · DOI · Paper page
- 10.1083/jcb.17.2.299 · DOI · Paper page
- 10.1006/excr.2001.5334 · DOI
- 10.1074/jbc.M604955200 · DOI · Paper page
- 10.1186/jbiol38 · DOI · Paper page
- 10.1074/jbc.M704428200 · DOI
- 10.1186/1471-2407-8-337 · DOI · Paper page
- 10.1093/emboj/16.8.1909 · DOI · Paper page
- 10.1128/MCB.19.3.1871 · DOI · Paper page
- 10.1038/35106593 · DOI · Paper page
- 10.1016/j.cub.2006.04.044 · DOI · Paper page
- 10.1038/ncb1676 · DOI · Paper page
- 10.1016/j.immuni.2008.02.015 · DOI · Paper page
- 10.1080/02699050500284218 · DOI · Paper page
- 10.1186/gb-2003-4-10-r69 · DOI · Paper page
- 10.4161/cbt.4.9.1912 · DOI
Cited by
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
RAF-MEK-ERK pathway in cancer evolution and treatment
Ullah, R., Yin, Q., Snell, A. H., & Wan, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.010 · Cited by 553
The ERK Cascade: Distinct Functions within Various Subcellular Organelles
Wortzel, I., & Seger, R. (2011) · Genes & Cancer · doi:10.1177/1947601911407328 · Cited by 563
ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?
Buscà, R., Pouysségur, J., & Lenormand, P. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00053 · Cited by 284
Metadata
- Authors
- Voisin, L., Saba-El-Leil, M. K., Julien, C., Frémin, C., & Meloche, S.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2010-06-01
- Volume
- 30
- Issue
- 12
- Pages
- 2918-2932
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2100482653
- Cited by
- 92
- References
- 11
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.